CN · Field Sheet
FIELD SHEET — HOLY BASIL MFI-HOLYBA-20261008-FS
Survey index / HOLY BASIL

Holy basil.

Ocimum tenuiflorum, Ocimum sanctum, Ocimum basilicum, Ocimum americanum
Ocimum species; adaptogenic and metabolic research coverage.
SEALED MFI-HOLYBA-20261008-FS · RELEASED 2026-10-08
SHEET FINGERPRINTMFI-HOLYBA-20261008-FS
205INCLUDED
1,309EXCLUDED
97DUPLICATE
87NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
1,698records surveyed
205studies
24claims graded
70observations
5,655graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-b7dfad74aff334d9GRADE VERY_LOW
holy basil constituents — inflammation
direction BENEFIT · dose 100 mg/kg; 400 mg/kg; 560 mg/kg · duration 14 days; 24 days; 8 weeks
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
7bound studies
Bound studies (4 shown of 7)
STU-13c35c3c4289eb52
ANIMAL · ANIMAL · 2014 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-1d1eeb773fb93fad
IN_VITRO · IN_VITRO · 2024 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-1e7fc6b383e8f6f6
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-2633e8088863a68f
ANIMAL · ANIMAL · 2021 · 24 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
effect p = 0.002 | p < 0.01 · failed extraction
n 6 · validated
duration 24 days · failed extraction
Opposition screen
SCREEN · 12 candidates considered · 0 bound as opposing
SYNTHESIS SYN-4a27ba45a7c729 — outcome QUALITATIVE_ONLY · BENEFIT ×7 · not_assessed_quantitatively · 7 members
PROVENANCE → epmc:24732112, epmc:38523946, epmc:42753948 · PKG f1e6bdad7d7c252e…
CLAIM · CLM-1535d6ebf8dc66f9GRADE LOW
holy basil constituents — mood
direction BENEFIT · dose 100 mg/kg; 400 mg/kg · duration 14 days; 8 weeks
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
6bound studies
Bound studies (4 shown of 6)
STU-00c6988139ea2725
IN_VITRO · IN_VITRO · 2024 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-2661b86eba48f1a5
IN_VITRO · IN_VITRO · 2023 · 8 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-42cc359101772771
RCT · HUMAN · 2012 · RoB SOME_CONCERNS
2 endpoints
STU-58850b0b93b51e95
ANIMAL · ANIMAL · 2024 · 14 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
p_value p < 0.01 · validated
duration 8 weeks · failed extraction
dose 400 mg/kg · validated
Opposition screen
SCREEN · 6 candidates considered · 0 bound as opposing
SYNTHESIS SYN-4cae7995c8acfe — outcome QUALITATIVE_ONLY · BENEFIT ×6 · not_assessed_quantitatively · 6 members
PROVENANCE → epmc:39065528, epmc:36670131, epmc:21977056 · PKG f1e6bdad7d7c252e…
Bounded preview — representative records only. The full release ships 24 claims and 70 observations.